Cargando…

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

Detalles Bibliográficos
Autores principales:	Kasper, Philipp, Demir, Münevver, Steffen, Hans-Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121306/ https://www.ncbi.nlm.nih.gov/pubmed/36935647 http://dx.doi.org/10.3350/cmh.2023.0059

Ejemplares similares

Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
por: Martin, Anna, et al.
Publicado: (2022)

Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools
por: Lang, Sonja, et al.
Publicado: (2020)

A holistic approach is needed to overcome the obesity epidemic
por: The Lancet Regional Health – Europe
Publicado: (2022)

Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
por: Roderburg, Christoph, et al.
Publicado: (2023)

Holistic Approach in the Management of Nonalcoholic Fatty Liver Disease
por: Shrestha, Ananta, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes
por: Loosen, Sven H, et al.
Publicado: (2021)

Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach?
por: Verduci, Elvira, et al.
Publicado: (2015)

Multimodal Therapy: Holistic Approach
por: Srinivasan, TM
Publicado: (2018)

The growing burden of non-alcoholic fatty liver disease on mortality
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Optimal diagnosis and management of non-alcoholic fatty liver disease
Publicado: (2022)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
por: Wang, Yinhan, et al.
Publicado: (2023)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
por: O'Brien, Alastair
Publicado: (2022)

Social prescribing: addressing societies holistic health-care needs
por: EClinicalMedicine
Publicado: (2021)

Medical science, technology and digital health – Need for holistic integration
por: Garg, Rakesh
Publicado: (2023)

Mucosa-associated microbiota alterations in primary sclerosing cholangitis (PSC) before and after liver transplantation—who is calling the shots?
por: Demir, Münevver, et al.
Publicado: (2023)

Holistic Approach to Tuberculosis Detection, Treatment and Prevention: Emerging Evidence and Strategies from the Field
por: Zafar Ullah, Abu Naser, et al.
Publicado: (2022)

Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
por: Eshraghian, Ahad
Publicado: (2017)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
por: Shim, Ju Hyun
Publicado: (2020)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease
por: Zoncapè, Mirko, et al.
Publicado: (2022)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
por: Teng, Margaret LP, et al.
Publicado: (2023)

Optimizing Glaucoma Care: A Holistic Approach
por: Dada, Tanuj, et al.
Publicado: (2023)

Increasing colorectal cancer screening uptake—time to consider a more holistic socio-ecological approach
por: Lau, Jerrald, et al.
Publicado: (2022)

The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients
por: Cetin, Elif Guven, et al.
Publicado: (2020)

neurodegeneration disorders need holistic care and treatment – can ayurveda meet the challenge?
por: Lakhotia, Subhash C.
Publicado: (2013)

Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
por: Jansen, Peter L. M.
Publicado: (2021)

Quantitative imaging tests for non-alcoholic fatty liver disease: which, when and why
por: Dennis, Andrea
Publicado: (2023)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9er912l7tvfntvuqg41sbp6fcn